Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
NCT02145689
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
The study was withdrawn prior to enrollment due to corporate decision.
Conditions
Muscle Spasticity
Stroke
Interventions
BIOLOGICAL:
onabotulinumtoxinA
Sponsor
Allergan